首页> 外文OA文献 >Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer

【2h】

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer

机译：弹性设计：一项比较卡培他滨联合索拉非尼或安慰剂治疗局部晚期或转移性HER2阴性乳腺癌的3期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Baselga, J; Costa, F; Gomez, H; Hudis, C; Rapoport, B; Roche, H; Schwartzberg, LS; Petrenciuc, O; Shan, M; Gradishar, WJ;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer [J] . J Baselga, F Costa, H Gomez, Breast Cancer Research . 2011,第Suppla2期

机译：弹性设计：一项比较卡培他滨与索拉非尼或安慰剂治疗局部晚期或转移性HER2阴性乳腺癌的3期试验
2. A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial [J] . José Baselga, Frederico Costa, Henry Gomez, Trials . 2013,第1期

机译：比较卡培他滨E与索拉非单抗或pLacebo联合治疗局部晚期或转移性HER2阴性乳腺癌CancEr的3期试验（RESILIENCE研究）：一项随机对照试验的研究方案
3. RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer [J] . José Baselga, Claudio Zamagni, Patricia Gómez, Clinical breast cancer . 2017,第8期

机译：弹性：III期随机，双盲试验将Sorafenib与CapeCitabine与Capecitabine在局部晚期或转移的Her2阴性乳腺癌中进行比较
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Diffusion-weighted magnetic resonance imaging in monitoring treatment response in patients with locally advanced breast cancer. [D] . Singer, Lisa. 2010

机译：扩散加权磁共振成像可监测局部晚期乳腺癌患者的治疗反应。
6. Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer [O] . J Baselga, F Costa, H Gomez, 2011

机译：弹性设计：一项比较卡培他滨与索拉非尼或安慰剂治疗局部晚期或转移性HER2阴性乳腺癌的3期试验
7. A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial [O] . José Baselga, Frederico Costa, Henry Gomez, 2013

机译：第3阶段比较卡培他滨E与SorafenIb或pLacebo联合治疗局部晚期或转移性HER2阴性乳腺癌CancEr（RESILIENCE研究）：一项随机对照试验的研究方案

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅